Cell-type-specific roles for COX-2 in UVB-induced skin cancer

Carcinogenesis

Volumn 35, Issue 6, 2014, Pages 1310-1319

  Jiao, Jing ^a   Mikulec, Carol ^b   Ishikawa, Tomo O ^c   Magyar, Clara ^a   Dumlao, Darren S ^d   Dennis, Edward A ^d   Fischer, Susan M ^b   Herschman, Harvey ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c KANAZAWA UNIVERSITY   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; CYCLOOXYGENASE 2; CYTOKERATIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CELLS BY BODY ANATOMY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR PROMOTION; TUMOR VASCULARIZATION; ULTRAVIOLET B RADIATION; ANIMAL; ANTIBODY SPECIFICITY; BONE MARROW CELL; CELL PROLIFERATION; DISEASE MODEL; DNA DAMAGE; EPIDERMIS; EPITHELIUM CELL; GENE EXPRESSION; GENE TARGETING; GENETICS; HOMOZYGOTE; HUMAN; HYPERPLASIA; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RADIATION EXPOSURE; SKIN TUMOR; TRANSGENIC MOUSE; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DNA DAMAGE; EPIDERMIS; EPITHELIAL CELLS; GENE DELETION; GENE EXPRESSION; GENE TARGETING; HOMOZYGOTE; HUMANS; HYPERPLASIA; MICE; MICE, TRANSGENIC; MYELOID CELLS; NEOVASCULARIZATION, PATHOLOGIC; ORGAN SPECIFICITY; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84905397607     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu020     Document Type: Article

References (39)

1. Benavides, F. et al. (2009) The hairless mouse in skin research. J. Dermatol. Sci., 53, 10-18.
2. Müller-Decker, K. (2011) Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence. Cancer Metastasis Rev., 30, 343-361.
3. Rouzer, C.A. et al. (2009) Cyclooxygenases: structural and functional insights. J. Lipid Res., 50 (suppl.), S29-S34.
4. Smith, W.L. et al. (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem., 69, 145-182.
5. An, K.P. et al. (2002) Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches. Photochem. Photobiol., 76, 73-80.
6. Athar, M. et al. (2001) Ultraviolet B(UVB)-induced cox-2 expression in murine skin: an immunohistochemical study. Biochem. Biophys. Res. Commun., 280, 1042-1047.
7. Rundhaug, J.E. et al. (2008) Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis. Photochem. Photobiol., 84, 322-329.
8. Johannesdottir, S.A. et al. (2012) Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study. Cancer, 118, 4768-4776.
9. Fischer, S.M. et al. (1999) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet lightinduced skin carcinogenesis. Mol. Carcinog., 25, 231-240.
10. Anderson, W.F., et al. (2003) Potential role of NSAIDs and COX-2 blockade in cancer therapy. In Harris, R.E. (ed) COX-2 Blockade in Cancer Prevention and Therapy. Humana Press, Totowa, NJ, pp. 313-340.
11. Pentland, A.P. et al. (2004) Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors. Cancer Res., 64, 5587-5591.
12. Fischer, S.M. et al. (2007) Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesis. Mol. Carcinog., 46, 363-371.
13. Greenhough, A. et al. (2009) The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis, 30, 377-386.
14. Pentland, A.P. et al. (1999) Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis, 20, 1939-1944.
15. Ishikawa, T.O. et al. (2006) Conditional knockout mouse for tissue-specific disruption of the cyclooxygenase-2 (Cox-2) gene. Genesis, 44, 143-149.
16. Ishikawa, T.O. et al. (2011) Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis. Carcinogenesis, 32, 417-426.
17. Narasimha, A.J. et al. (2010) Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null mice. Arterioscler. Thromb. Vasc. Biol., 30, 260-268.
18. Hill, R. et al. (2012) Cell intrinsic role of COX-2 in pancreatic cancer development. Mol. Cancer Ther., 11, 2127-2137.
19. Kietzmann, M. et al. (1990) The mouse epidermis as a model in skin pharmacology: influence of age and sex on epidermal metabolic reactions and their circadian rhythms. Lab. Anim., 24, 321-327.
20. Akunda, J.K. et al. (2007) Cyclooxygenase-2 deficiency increases epidermal apoptosis and impairs recovery following acute UVB exposure. Mol. Carcinog., 46, 354-362.
21. Tripp, C.S. et al. (2003) Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection. J. Invest. Dermatol., 121, 853-861.
22. Svobodová, A.R. et al. (2012) DNA damage after acute exposure of mice skin to physiological doses of UVB and UVA light. Arch. Dermatol. Res., 304, 407-412.
23. RajnochováSvobodová, A. et al. (2013) Effects of oral administration of Lonicera caerulea berries on UVB-induced damage in SKH-1 mice. A pilot study. Photochem. Photobiol. Sci., 12, 1830-1840.
24. Lu, Y.P. et al. (1999) Time course for early adaptive responses to ultraviolet B light in the epidermis of SKH-1 mice. Cancer Res., 59, 4591-4602.
25. Athar, M. et al. (2004) Photoprotective effects of sulindac against ultraviolet B-induced phototoxicity in the skin of SKH-1 hairless mice. Toxicol. Appl. Pharmacol., 195, 370-378.
26. Fuchs, E. (2009) Finding one's niche in the skin. Cell Stem Cell, 4, 499-502.
27. Zhu, S. et al. (1999) C/EBPbeta modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression. Mol. Cell. Biol., 19, 7181-7190.
28. Tiano, H.F. et al. (2002) Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res., 62, 3395-3401.
29. Abel, E.L. et al. (2009) Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat. Protoc., 4, 1350-1362.
30. DuBois, R.N. (2003) Cyclooxygenase-2 and colorectal cancer. Prog. Exp. Tumor Res., 37, 124-137.
31. Ghosh, N. et al. (2010) COX-2 as a target for cancer chemotherapy. Pharmacol. Rep., 62, 233-244.
32. Fischer, S.M. et al. (2011) Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention. Cancer Prev. Res. (Phila)., 4, 1728-1735.
33. Kemp, C.J. (2005) Multistep skin cancer in mice as a model to study the evolution of cancer cells. Semin. Cancer Biol., 15, 460-473.
34. Brash, D.E. et al. (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl Acad. Sci. USA, 88, 10124-10128.
35. Giglia-Mari, G. et al. (2003) TP53 mutations in human skin cancers. Hum. Mutat., 21, 217-228.
36. Li, G. et al. (1995) Ultraviolet radiation induction of squamous cell carcinomas in p53 transgenic mice. Cancer Res., 55, 2070-2074.
37. Viarisio, D. et al. (2011) E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog., 7, e1002125.
38. Markosyan, N. et al. (2011) Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumors. Carcinogenesis, 32, 1441-1449.
39. Lao, H.C. et al. (2012) Genetic ablation of cyclooxygenase-2 in keratinocytes produces a cell-autonomous defect in tumor formation. Carcinogenesis, 33, 2293-2300.